Trials / Sponsors / Calibr, a division of Scripps Research
Calibr, a division of Scripps Research
Academic / Other · 10 registered clinical trials — 3 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | CLF065 for Chronic Pouchitis Pouchitis | Phase 2 | 2026-03-05 |
| Withdrawn | A Study to Assess CLBR001+SWI019 in Subjects With Autoimmune Diseases Systemic Lupus Erythematosus (SLE), Systemic Sclerosis (SSc), Idiopathic Inflammatory Myopathy (IIM) | Phase 1 | 2026-03-01 |
| Enrolling By Invitation | Long Term Follow-up Study for Subjects Administered CLBR001 Long Term Follow-Up | — | 2025-08-28 |
| Active Not Recruiting | A Study to Assess CLBR001+ABBV-461 in Subjects With Locally Advanced or Metastatic Breast Cancer Breast Cancer Metastatic, Locally Advanced Breast Cancer (LABC), Malignant Neoplasm of Breast | Phase 1 | 2025-04-17 |
| Recruiting | Study to Assess CMR316 in Healthy Volunteers and Patients With Idiopathic Pulmonary Fibrosis Pulmonary Fibroses, Idiopathic | Phase 1 | 2024-08-19 |
| Completed | Study to Assess PDM608 in Healthy Adult Subjects Parkinson Disease | Phase 1 | 2023-06-27 |
| Completed | Long-term Follow-up Study for Patients Treated With CLBR001 CAR-T Relapsed/Refractory B-cell Lymphomas, Diffuse Large B-Cell Lymphoma (DLBCL), Follicular Lymphoma (FL) | Phase 1 | 2021-01-21 |
| Completed | CLBR001 and SWI019 in Patients With Relapsed / Refractory B-cell Malignancies Relapsed/Refractory B-cell Lymphomas, Diffuse Large B Cell Lymphoma (DLBCL), Follicular Lymphoma (FL) | Phase 1 | 2020-08-14 |
| Terminated | First-in-human Study of CCW702 in Patients With Metastatic Castration Resistant Prostate Cancer Metastatic Castration-Resistant Prostate Adenocarcinoma | Phase 1 | 2020-07-17 |
| Completed | A Study Evaluating the Safety, Pharmacokinetics, and Pharmacodynamics of KA34 in Subjects With Knee Osteoarthr Osteoarthritis, Knee | Phase 1 | 2018-05-02 |